v1
Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer.
Identifier:nobleid.org/w1/20260515/5D9ADEBA
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/5D9ADEBA)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims